NCT02762812View on ClinicalTrials.gov

Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis

PHASE3CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

July 31, 2017

Conditions
Ankylosing Spondylitis
Interventions
BIOLOGICAL

BCD-055

BIOLOGICAL

Remicade®

Trial Locations (1)

Unknown

North-Western State Medical University n.a. I.I.Mechnikov, Saint Petersburg

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY

NCT02762812 - Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter